More
    Guided Solutions - Connecting Talent With Innovation/div>

    Neurovalens brings in $8.1m for neurostimulation technology

    Neurovalens closed an investment round worth approximately $8.1 million (£6 million) in proceeds. The Investment Fund for Northern Ireland (IFNI) led the financing round for...

    Vivani closes $10M financing, advances GLP-1 implant

    Vivani Medical announced that it brought in $10 million in equity financing as it progresses its drug delivery technology. Alameda, California-based Vivani develops NanoPortal technology,...

    Reprieve Cardiovascular raised $61m for heart failure treatment system

    Reprieve Cardiovascular closed an oversubscribed Series B financing totaling $61 million. Deerfield Management led the funding round. Arboretum Ventures, Lightstone Ventures, Sante Ventures, Genesis Capital,...

    Conformal Medical closes $32m Series D extension

    Conformal Medical closed a Series D extension financing totaling $32 million in proceeds. The company originally completed its Series D round in 2023, bringing in...

    SetPoint Medical raises $140m to support its arthritis neuromod implant

    SetPoint Medical raised $140 million in private financing, including a second Series C tranche and its Series D round. The financing includes $25 million in...

    CardiacBooster secures $10.8m for ventricular assist device

    A consortium led by CardiacBooster, in partnership with Fire1 and Integer, received $10.8 million (€9.3 million in funding) recently. The funding, from Ireland’s Disruptive Technologies...

    Apreo Health raises $130m to fund emphysema implant pivotal trial

    California-based startup Apreo Health has raised $130m to further the development of its implant for treating severe emphysema. The Series B round was co-led by...

    Sava lands $19m for world-first biosensor to disrupt real-time health monitoring

    London-based healthtech startup Sava Technologies Ltd. has raised $19 million in Series A funding, following a major clinical achievement for its proprietary microsensor platform....

    Ultromics lands $55m Series C to tackle undiagnosed heart failure at scale

    Ultromics, a pioneer in AI-driven cardiology solutions, today announced it has raised $55 million in Series C financing. The round was co-led by L&G,...

    Latest articles